Literature DB >> 4052442

Substrate inhibition of carnitine palmitoyltransferase by palmitoyl-CoA and activation by phospholipids and proteins.

G Woldegiorgis, J Bremer, E Shrago.   

Abstract

When carnitine palmitoyltransferase is purified it shows increasing substrate inhibition by palmitoyl-CoA as the protein content of the assay mixture is decreased. The purified enzyme is stimulated by addition of phospholipids (phosphatidylcholine, cardiolipin) and proteins (albumin, fatty acid-binding protein, lambda-globulin) to the reaction mixture. The effects of phospholipid and protein are more than additive, particularly with relatively high concentrations of palmitoyl-CoA. It is suggested that the enzyme contains hydrophobic sites which require phospholipid to prevent spurious binding of palmitoyl-CoA and which normally anchor the enzyme to the mitochondrial membrane.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4052442     DOI: 10.1016/0005-2760(85)90236-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  20 in total

Review 1.  Liver fatty acid-binding protein and obesity.

Authors:  Barbara P Atshaves; Gregory G Martin; Heather A Hostetler; Avery L McIntosh; Ann B Kier; Friedhelm Schroeder
Journal:  J Nutr Biochem       Date:  2010-11       Impact factor: 6.048

2.  Liver fatty acid-binding protein gene-ablated female mice exhibit increased age-dependent obesity.

Authors:  Gregory G Martin; Barbara P Atshaves; Avery L McIntosh; John T Mackie; Ann B Kier; Friedhelm Schroeder
Journal:  J Nutr       Date:  2008-10       Impact factor: 4.798

3.  Enzymes of carnitine acylation. Is overt carnitine palmitoyltransferase of liver peroxisomal carnitine octanoyltransferase?

Authors:  M J Healy; J Kerner; L L Bieber
Journal:  Biochem J       Date:  1988-01-01       Impact factor: 3.857

4.  Lack of activation of the S113L variant of carnitine palmitoyltransfersase II by cardiolipin.

Authors:  Leila Motlagh Scholle; Annemarie Thaele; Marie Beckers; Beate Meinhardt; Stephan Zierz
Journal:  J Bioenerg Biomembr       Date:  2019-01-03       Impact factor: 2.945

5.  Hepatic ATGL mediates PPAR-α signaling and fatty acid channeling through an L-FABP independent mechanism.

Authors:  Kuok Teong Ong; Mara T Mashek; Nicholas O Davidson; Douglas G Mashek
Journal:  J Lipid Res       Date:  2014-03-08       Impact factor: 5.922

6.  Comparison of the active sites of the purified carnitine acyltransferases from peroxisomes and mitochondria by using a reaction-intermediate analogue.

Authors:  N Nic a' Bháird; G Kumaravel; R D Gandour; M J Krueger; R R Ramsay
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

7.  Liver fatty acid binding protein gene-ablation exacerbates weight gain in high-fat fed female mice.

Authors:  Avery L McIntosh; Barbara P Atshaves; Danilo Landrock; Kerstin K Landrock; Gregory G Martin; Stephen M Storey; Ann B Kier; Friedhelm Schroeder
Journal:  Lipids       Date:  2013-03-29       Impact factor: 1.880

8.  Inhibition of carnitine palmitoyltransferase in normal human skeletal muscle and in muscle of patients with carnitine palmitoyltransferase deficiency by long- and short-chain acylcarnitine and acyl-coenzyme A.

Authors:  S Zierz; S Neumann-Schmidt; F Jerusalem
Journal:  Clin Investig       Date:  1993-10

9.  Hepatic carnitine palmitoyltransferase turnover and translation rates in fed, starved, streptozotocin-diabetic and diethylhexyl phthalate-treated rats.

Authors:  P S Brady; L J Brady
Journal:  Biochem J       Date:  1987-09-15       Impact factor: 3.857

Review 10.  Role of fatty acid binding proteins and long chain fatty acids in modulating nuclear receptors and gene transcription.

Authors:  Friedhelm Schroeder; Anca D Petrescu; Huan Huang; Barbara P Atshaves; Avery L McIntosh; Gregory G Martin; Heather A Hostetler; Aude Vespa; Danilo Landrock; Kerstin K Landrock; H Ross Payne; Ann B Kier
Journal:  Lipids       Date:  2007-09-19       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.